×

Message

EU e-Privacy Directive

This website uses cookies to manage authentication, navigation, and other functions. By using our website, you agree that we can place these types of cookies on your device.

View e-Privacy Directive Documents

You have declined cookies. This decision can be reversed.

Diagnosis on which method may be applied therapeutically.

(Other options under consultation)

Acute gallbladder inflammation (PBC)

Addison's disease

Aging

Allergies

Alopecia areata

Amyotrophic Laterla Scelrosis

Antiphospholipid syndrome – Vasculitis  (APS) Pemphigus and pemphigoid

Asthma

Atopic Eczema

Autism

Autoimmune Diseases of Thyroid Gland i.e. Basedow

Cancer

Cardiovascular Diseases

Celiac disease

Chronic Leucocyte leucemia

Chronic atrophic gastritis (GCA) of type A and B

Chronic heart failure

Crohn's disease

Dermatopolymyositis (SM / PM)

Depression

Fatigue Syndrome

Goodpasture syndrome

Graves' disease (TAI)

Heart Disease

Hashimoto – primary myxedema

Hepatitis B, C

Infertility

Mixed connective tissue disease or Sharp syndrome (MCTD)

MYASTEHNIA GRAVIS

Multiple Myeloma

Multiple Sclerosis

Oncological Deceases – as i.e. Leukemia

Ostearthrtis

Oxigenoterapie

Pernicious anemia

Pluriendocrine autoimmune syndrome (SPA) type I, II, III, IV

Primary biliary cirrhosis (PBC)

Psoriasis

Purulent inflammation of the intestine (RCU)

Rheumatoid arthritis / Morbus Bechterev (AR)

Systemic lupus erythematodes (LES)

Systemic sclerosis (SSc)

Therapy of tumors with biomodulation

REGISTERED: Handelsregister Schwyz
COMPANY NUMBER: CH-1029-379-06
TAX NUMBER: 1029-379-06
Copyright © 2017. All Rights Reserved.
Institute for Biomodulation Medicine AG

SCHWERZISTRASSE 4, CH-8807 FREIENBACH (CH)
PHONE: +41 41 5003753 FAX: +41 41 5003754
EMAIL: INFO@BIOMODULATION.ORG

logo

INSTITUTE FOR BIOMODULATION
MEDICINE

0.png0.png2.png8.png7.png9.png1.png7.png
Today223
Yesterday369
This week1370
This month5414
Total287917

Thursday, 14 December 2017 17:07